Carboplatin Injection — FDA Drug Shortage

To Be Discontinued — Teyro Labs

The FDA lists a drug shortage record for Carboplatin Injection (injection) from Teyro Labs with status To Be Discontinued. The shortage was first posted on Jun 1, 2026.

Shortage details

Status
To Be Discontinued
Company
Teyro Labs
Package NDC
60505-6282-3
Dosage Form
Injection
Presentation
Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-3)
Initial Posting
Jun 1, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.